Identification of baicalin from Bofutsushosan and Daisaikoto as a potent inducer of glucose uptake and modulator of insulin signaling-associated pathways

doi:10.1016/j.jfda.2018.07.002

Chia Nan University of Pharmacy & Science Institutional Repository > 藥理學院 > 保健營養系(所) > 期刊論文 > Item 310902800/32508

請使用永久網址來引用或連結此文件: https://ir.cnu.edu.tw/handle/310902800/32508

標題:	Identification of baicalin from Bofutsushosan and Daisaikoto as a potent inducer of glucose uptake and modulator of insulin signaling-associated pathways
作者:	Kuo, Yu-Ting Lin, Chih-Chan Hsiao-Tzu Kuo(郭小慈) Jui-Hsiang Hung(洪瑞祥) Liu, Ching-Hsuan Jassey, Alagie Yen, Ming-Hong Shu-Jing Wu(吳淑靜) Lin, Liang-Tzung
貢獻者:	Chi Mei Med Ctr, Dept Med Imaging Chi Mei Med Ctr, Dept Med Res Chia Nan Univ Pharm & Sci, Dept Nutr Hlth Chia Nan Univ Pharm & Sci, Dept Biotechnol Taipei Med Univ, Grad Inst Med Sci, Coll Med Dalhousie Univ, Dept Microbiol & Immunol Taipei Med Univ, Coll Med, Int PhD Program Med Kaohsiung Med Univ, Coll Pharm, Grad Inst Nat Prod Taipei Med Univ, Sch Med, Dept Microbiol & Immunol, Coll Med
關鍵字:	Anti-hyperglycemia Baicalin Bofutsushosan Daisaikoto Glucose uptake
日期:	2019-01
上傳時間:	2020-07-29 13:47:52 (UTC+8)
出版者:	FOOD & DRUG ADMINSTRATION
摘要:	Type 2 diabetes mellitus (T2DM) is a chronic disease characterized by hyperglycemia that can lead to long-term complications including heart diseases, stroke, retinopathy, and renal failure. Treatment strategies include stimulating glucose uptake and controlling blood glucose level. Bofutsushosan (BOF) and Daisaikoto (DAI) are two herb-based kampo medicines that have been demonstrated to improve metabolism-associated disorders including obesity, hyperlipidemia, and nonalcoholic fatty liver. Given their bioactivities against metabolic syndromes, we explored in this study the effect of BOF and DAI extracts on glucose absorption and used them as source to identify phytochemical stimulator of glucose absorption. Glucose uptake and mechanistic studies were evaluated in differentiated C2C12 skeletal muscle cells, and HPLC analysis was used to determine the molecular bioactive constituents. Our results indicated that the ethanolic extracts of BOF and DAI (BOFEE and DAIEE, respectively) enhanced the glucose uptake ratio in the differentiated C2C12 cells, and further analysis identified the flavone baicalin as a major constituent capable of efficiently stimulating glucose absorption. Mechanistic studies revealed that the effect from baicalin involved the activation of IRS-1 and GLUT-4, and implicated the AMPK, PI3K/Akt, and MAPK/ERK signaling cascades. Due to its potency, we suggest that baicalin merit further evaluation as a potential candidate anti-hyperglycemic agent for the treatment and management of T2DM. Copyright (C) 2018, Food and Drug Administration, Taiwan. Published by Elsevier Taiwan LLC.
關聯:	Journal of Food and Drug Analysis, v.27, n.1, pp.240-248
顯示於類別:	[保健營養系(所) ] 期刊論文 [生物科技系(所)] 期刊論文

文件中的檔案:

檔案	描述	大小	格式	瀏覽次數
10.1016-j.jfda.2018.07.002.pdf		880Kb	Adobe PDF	439	檢視/開啟
index.html		0Kb	HTML	1431	檢視/開啟

在CNU IR中所有的資料項目都受到原著作權保護.

TAIR相關文章

資料載入中.....